Cyclin B2 (CCNB2) serves as a diagnostic and prognostic marker in various human tumors, including HCC [187], rhabdomyosarcoma [188], TNBC [189], and low-grade glioma [190]. This evidence concerns the gene CCNB2 and central nervous system cancer.